Stock Alert: Lorillard (NYSE:LO), 3D Systems Corporation (NYSE:DDD), American Public Education (NASDAQ:APEI), TeleCommunication Systems (NASDAQ:TSYS), Eli Lilly and Company (NYSE:LLY)


Lorillard, Inc. (NYSE:LO) announced that its Board of Directors approved a 7% increase in the quarterly dividend on its common stock from $0.615 per share to $0.66 per share. The dividend is payable on March 10, 2015 to stockholders of record as of March 2, 2015. On Friday shares of Lorillard, Inc. (NYSE:LO) closed at $66.99. Company’s sales growth for last 5 years was 6.00% and EPS growth for next 5 years is recorded as 9.00%.

3D Systems Corporation (NYSE:DDD) had its price target lowered by analysts at Deutsche Bank from $43.00 to $33.00. They now have a “hold” rating on the stock.On Friday shares of 3D Systems Corporation (NYSE:DDD) closed at $28.50. Company’s sales growth for last 5 years was 42.10% and EPS growth for next 5 years is recorded as 21.33%.

On February 26, American Public Education Inc. (NASDAQ:APEI) reported fourth-quarter profit of $11.8 million. For the year, the company reported profit of $40.9 million, or $2.33 per share. Revenue was reported as $350 million. On last trading day American Public Education, Inc. (NASDAQ:APEI) moved down -0.43% to close at $30.20. Its volatility for the week is 2.86% while volatility for the month is 2.82%. APEI’s sales growth for past 5 years was 25.20% and its EPS growth for past 5 years was 22.30%. American Public Education, Inc. (NASDAQ:APEI) monthly performance is -13.09%.

TeleCommunication Systems, Inc. (NASDAQ:TSYS) has been invited to present at the 27th Annual ROTH Conference. The conference is being held on March 8-11, 2015 at The Ritz Carlton in Dana Point, California. TeleCommunication Systems Inc. (NASDAQ:TSYS) has 4.30% insider ownership while its institutional ownership stands at 62.40%. In last trading activity company’s stock closed at $3.17.

The German Court of Appeal has ruled that Eli Lilly and Company’s (NYSE:LLY) vitamin regimen patent for Alimta (pemetrexed disodium) would not be infringed by a generic competitor that intends to market a dipotassium salt form of pemetrexed in Germany once the compound patent expires in December 2015.Eli Lilly and Company (NYSE:LLY) in last trading activity fell -3.09% to close at $68.41. Company weekly performance is -2.51% while its quarterly performance stands at -3.14%. Eli Lilly and Company (NYSE:LLY) is -8.25% away from its 52 week high.


Leave a Reply

Your email address will not be published. Required fields are marked *